Vascular Biology Research Group, Department of Medical Biology, University of Tromsø (UiT), The Arctic University of Norway, 9010 Tromsø, Norway.
Department of Biophysical Microstructures, Institute of Nuclear Physics, Polish Academy of Sciences, 31-342 Kraków, Poland.
Int J Mol Sci. 2022 Aug 30;23(17):9850. doi: 10.3390/ijms23179850.
Liver sinusoidal endothelial cells (LSECs) facilitate the efficient transport of macromolecules and solutes between the blood and hepatocytes. The efficiency of this transport is realized via transcellular nanopores, called fenestrations. The mean fenestration size is 140 ± 20 nm, with the range from 50 nm to 350 nm being mostly below the limits of diffraction of visible light. The cellular mechanisms controlling fenestrations are still poorly understood. In this study, we tested a hypothesis that both Rho kinase (ROCK) and myosin light chain (MLC) kinase (MLCK)-dependent phosphorylation of MLC regulates fenestrations. We verified the hypothesis using a combination of several molecular inhibitors and by applying two high-resolution microscopy modalities: structured illumination microscopy (SIM) and scanning electron microscopy (SEM). We demonstrated precise, dose-dependent, and reversible regulation of the mean fenestration diameter within a wide range from 120 nm to 220 nm and the fine-tuning of the porosity in a range from ~0% up to 12% using the ROCK pathway. Moreover, our findings indicate that MLCK is involved in the formation of new fenestrations-after inhibiting MLCK, closed fenestrations cannot be reopened with other agents. We, therefore, conclude that the Rho-ROCK pathway is responsible for the control of the fenestration diameter, while the inhibition of MLCK prevents the formation of new fenestrations.
肝窦内皮细胞 (LSEC) 促进血液和肝细胞之间大分子和溶质的有效转运。这种转运的效率是通过称为窗孔的细胞间纳米孔来实现的。窗孔的平均直径为 140±20nm,范围从 50nm 到 350nm,主要低于可见光的衍射极限。控制窗孔的细胞机制仍知之甚少。在这项研究中,我们检验了一个假设,即 Rho 激酶 (ROCK) 和肌球蛋白轻链激酶 (MLCK) 依赖性肌球蛋白轻链磷酸化调节窗孔。我们使用几种分子抑制剂的组合,并应用两种高分辨率显微镜模式:结构照明显微镜 (SIM) 和扫描电子显微镜 (SEM),验证了这一假设。我们证明了 ROCK 通路能够精确、剂量依赖性地、可逆地调节窗孔平均直径在 120nm 至 220nm 的宽范围内,以及在 0%至 12%的范围内精细调节通透性。此外,我们的发现表明,MLCK 参与新窗孔的形成-抑制 MLCK 后,其他试剂无法使关闭的窗孔重新开放。因此,我们得出结论,Rho-ROCK 途径负责控制窗孔直径,而抑制 MLCK 可防止新窗孔的形成。